CPC on The Bethesda System for Reporting Thyroid Cytopathology
Introduction
Fine-needle aspiration (FNA) is the most important initial investigation for evaluating thyroid nodules in euthyroid patients. In the past, variability in terminology and reporting of thyroid cytology across laboratories led to confusion in diagnosis and management. To address these issues, the National Cancer Institute (NCI) introduced The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) in 2007, providing a standardized reporting format.
The Bethesda system categorizes thyroid FNA results into six well-defined diagnostic categories, each associated with an estimated risk of malignancy and recommended clinical management. This standardized approach has improved communication between cytopathologists and clinicians, reduced unnecessary surgeries, and enhanced detection of thyroid malignancies.
Key Points
Role and Impact of Thyroid FNA
Best initial test for thyroid nodules.
Simple, safe, cost-effective, and highly sensitive.
Reduced unnecessary thyroid surgeries.
Increased diagnostic yield for malignancy.
Bethesda Diagnostic Categories
Category I: Nondiagnostic / Unsatisfactory
Inadequate cellularity or poor sample quality.
Management: Repeat FNA after an appropriate interval, preferably under ultrasound guidance.
Category II: Benign
Includes benign follicular nodules, Hashimoto’s thyroiditis, and subacute thyroiditis.
Very low risk of malignancy.
Management: Clinical and ultrasound follow-up.
Category III: Atypia of Undetermined Significance / Follicular Lesion of Undetermined Significance (AUS/FLUS)
Cytological atypia insufficient for a definitive diagnosis.
Management: Clinical correlation and repeat FNA.
Category IV: Follicular Neoplasm / Suspicious for Follicular Neoplasm
Cellular aspirates with microfollicular architecture and scant colloid.
Management: Surgical excision (lobectomy or hemithyroidectomy).
Category V: Suspicious for Malignancy
Features suggestive but not diagnostic of malignancy.
Commonly suspicious for papillary thyroid carcinoma.
Management: Surgical intervention.
Category VI: Malignant
Definitive cytological features of malignancy.
Includes papillary, medullary, poorly differentiated, and anaplastic carcinoma.
Management: Total or near-total thyroidectomy with or without adjuvant therapy.
Reporting Format
Each report begins with a general diagnostic category.
Subcategorization and descriptive comments may be added when necessary.
Clear categorization aids in uniform clinical decision-making.
Clinical Importance
Provides risk stratification for malignancy.
Guides appropriate surgical and non-surgical management.
Enhances multidisciplinary communication.
